Proteomics International Laboratories Ltd (#ASX: $PIQ) announces a global multi centre study of 3,000 people has confirmed the effectiveness of PromarkerD as a predictive test for diabetic kidney disease. https://t.co/um2o12bc6W. #Medical #KidneyDisease #StockMarket #stocks https://t.co/7bwjGwogih